Abstract
The wide use of engineered nanomaterials in many fields, ranging from biomedical, agriculture, environment, cosmetic, urged the scientific community to understand the processes behind their potential toxicity, in order to develop new strategies for human safety. As a matter of fact, there is a big discrepancy between the increased classes of nanoparticles and the consequent applications versus their toxicity assessment. Nanotoxicology is defined as the science that studies the effects of engineered nanodevices and nanostructures in living organisms. This chapter analyzes the physico-chemical properties of the most used nanoparticles, the way they enter the living organism and their cytoxicity mechanisms at cellular exposure level. Moreover, the current state of nanoparticles risk assessment is reported and analyzed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hoyt VW, Mason E (2008) Nanotechnology. Emerging health issues. J Chem Health Saf 15:10–15
ISO, 2010. International Organization for Standardization. Nanotechnologies vocabulary part 1: Core Terms. ISO/TS 80004-1:2010
ISO (2008) International Organization for Standardization. Technical specification: nanotechnologies terminology and definitions for nanoobjects nanoparticle, nanofibre and nanoplate. ISO/TS 80004-2:2008
Oberdörster G, Stone V, Donaldson K (2007) Toxicology of nanoparticles: a historical perspective. Nanotoxicology 1:2–25
Wang Y, Xia Y (2004) Bottom-up and top-down approaches to the synthesis of monodispersed spherical colloids of low melting-point metals. Nano Lett 4(10):2047–2050
Silva GA (2006) Neuroscience nanotechnology: progress, opportunities and challenges. Nat Rev Neurosci 7:65–74
Ray PC, Fu PP (2010) Toxicity and environmental risks of nanomaterials: challenges and future needs. J Env Sci Heal C Env Carcinog Ecotoxicol Rev 27:1–35
Kango S, Kalia S, Celli A et al (2013) Surface modification of inorganic nanoparticles for development of organic-inorganic nanocomposites – a review. Prog Polym Sci 38:1232–1261
Oberdörster G, Oberdörster E, Oberdörster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823–839
Wiley B, Sun Y, Xia Y (2007) Synthesis of silver nanostructures with controlled shapes and properties. Acc Chem Res 40:1067–1076
Prasek J, Drbohlavova J, Chomoucka J et al (2011) Methods for carbon nanotubes synthesis—review. J Mater Chem 21:15872
Mu Q, Jiang G, Chen L et al (2014) Chemical basis of interactions between engineered nanoparticles and biological systems. Chem Rev 114(15):7740–7781
Evans SJ, Clift MJD, Singh N et al (2017) Critical review of the current and future challenges associated with advanced in vitro systems towards the study of nanoparticle (secondary) genotoxicity. Mutagenesis 32(1):233–241
Oberdörster G (2010) Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J Intern Med 267:89–105
Oberdörster G, Maynard A, Donaldson K et al (2005) Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8
Ma DD, Yang WX (2015) Engineered nanoparticles induce cell apoptosis: potential for cancer therapy. Oncotarget. 28 7(26):40882–40903
Hund-Rinke K, Herrchen M, Schlich K et al (2015) Test strategy for assessing the risks of nanomaterials in the environment considering general regulatory procedures. Environ Sci Eur 27:1–12
Stone V, Johnston H, Schins RPF (2009) Development of in vitro systems for nanotoxicology: methodological considerations. Crit Rev Toxicol 39:613–626
Fröhlich E, Salar-Behzadi S (2014) Toxicological assessment of inhaled nanoparticles: role of in vivo, ex vivo, in vitro, and in silico studies. Int J Mol Sci 15:4795–4822
(2010) Directive 2010/63/EU. http://ec.europa.eu/environment/chemicals/lab_animals/index_en.htm
Aillon KL, Xie Y, El-Gendy N et al (2009) Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv Drug Deliv Rev 61:457–466
Dechsakulthorn F, Hayes A, Bakand S et al (2007) In vitro cytotoxicity assessment of selected nanoparticles using human skin fibroblasts. Proceeding 6th World Congr Altern Anim Use Life Sci 397–400
Jones CF, Grainger DW (2009) In vitro assessments of nanomaterial toxicity. Adv Drug Deliv Rev 61(6):438–5636. 490–499
Barua S, Mitragotri S (2014) Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects Sutapa. Nano Today 9:223–243
Yah CS, Simate GS, Iyuke SE (2012) Nanoparticles toxicity and their routes of exposures. Pak J Pharm Sci 25(2):477–491
Qiao H, Liu W, Gu H et al (2015) The transport and deposition of nanoparticles in respiratory system by inhalation. J Nanomater 2015:394507. 8
Bakshi S, He ZL, Harris WG (2014) Natural nanoparticles: implications for environment and human health. Crit Rev Environ Sci Technol 45:861–904
Schneider M, Stracke F, Hansen S, Schaefer UF (2009) Nanoparticles and their interactions with the dermal barrier. Dermatoendocrinol 1:197–206
Li J, Chang X, Chen X et al (2014) Toxicity of inorganic nanomaterials in biomedical imaging. Biotechnol Adv 32:727–743
Oberdörster G, Sharp Z, Atudorei V et al (2004) Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol 16:437–445
Natarajan A, Gruettner C, Ivkov R et al (2008) Nanoferrite particle based radioimmunonanoparticles: binding affinity and in vivo pharmacokinetics. Biophys Chem 19:1211–1218
Powers KW, Palazuelos M, Moudgil BM, Roberts SM (2007) Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies. Nanotoxicology 1:42–51
Jiang J, Oberdörster G, Elder A et al (2008) Does nanoparticle activity depend upon size and crystal phase? Nanotoxicology 2(1):33–42
Souza TAJ, Franchi LP, Rosa LR et al (2016) Cytotoxicity and genotoxicity of silver nanoparticles of different sizes in CHO-K1 and CHO-XRS5 cell lines. Mutat Res Genet Toxicol Environ Mutagen 795:70–83
Yallapu MM, Ebeling MC, Jaggi M, Chauhan SC (2013) Plasma proteins interaction with curcumin nanoparticles: implications in cancer therapeutics. Curr Drug Metab 14:504–515
Gatoo MA, Naseem S, Arfat MY et al (2014) Physicochemical properties of nanomaterials: implication in associated toxic manifestations. Biomed Res Int. 498420, 8
Nemmar A, Yuvaraju P, Beegam S et al (2016) Oxidative stress, inflammation, and DNA damage in multiple organs of mice acutely exposed to amorphous silica nanoparticles. Int J Nanomedicine 11:919–928
Sonavane G, Tomoda K, Makino K (2008) Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B: Biointerfaces 66:274–280
De Jong WH, Hagens WI, Krystek P et al (2008) Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29:1912–1919
Braakhuis HM, Park MVDZ, Gosens I et al (2014) Physicochemical characteristics of nanomaterials that affect pulmonary inflammation. Part Fibre Toxicol 11:18
Ahamed M, Akhtar MJ, Alhadlaq HA, Alrokayan SA (2015) Assessment of the lung toxicity of copper oxide nanoparticles: current status. Nanomedicine(Lond) 10(15):2365–2377
Asgharian B, Price OT (2007) Deposition of ultrafine (nano) particles in the human lung. Inhal Toxicol 19:1045–1054
Von Garnier C (2013) Nanoparticles in the respiratory tract: modulation of antigen-presenting cell function. J Enviromental Immunol Toxicol 1:140
Kettler K, Veltman K, van de Meent D et al (2014) Cellular uptake of nanoparticles as determined by particle properties, experimental conditions, and cell type. Environ Toxicol Chem 33:481–492
Baharifar H, Amani A (2016) Cytotoxicity of chitosan/streptokinase nanoparticles as a function of size: An artificial neural networks study. Nanomedicine 12(1):171–180
Recordati C, De Maglie M, Bianchessi S et al (2016) Tissue distribution and acute toxicity of silver after single intravenous administration in mice: nano-specific and size-dependent effects. Part Fibre Toxicol 13:12
Chen Z, Meng H, Xing G et al (2006) Acute toxicological effects of copper nanoparticles in vivo. Toxicol Lett 163:109–120
Seiffert J, Hussain F, Wiegman C et al (2015) Pulmonary toxicity of instilled silver nanoparticles: Influence of size, coating and rat strain. PLoS One 10:1–17
Li Y, Monteiro-Riviere NA (2016) Mechanisms of cell uptake, inflammatory potential and protein corona effects with gold nanoparticles. Nanomedicine 11:3185–3203
Allegri M, Bianchi MG, Chiu M et al (2016) Shape-related toxicity of titanium dioxide nanofibres. PLoS One 11:1–21
Yokel RA (2016) Physicochemical properties of engineered nanomaterials that influence their nervous system distribution and effects. Nanomedicine Nanotechnol Biol Med 12:2081–2093
Verma A, Stellacci F (2010) Effect of surface properties on nanoparticle-cell interactions. Small 6:12–21
Oh N, Park JH (2014) Endocytosis and exocytosis of nanoparticles in mammalian cells. Int J Nanomedicine 9:51–63
Nangia S, Sureshkumar R (2012) Efects of nanoparticle charge and shape anisotropy on traslocation through cell membranes. Langmuir 28:1766
Zhang X-F, Liu Z-G, Shen W, Gurunathan S (2016) Silver nanoparticles: synthesis, characterization properties, applications, and therapeutic approaches. Int J Mol Sci 17:1534
Hsiao I-L, Huang Y-J (2011) Effects of various physicochemical characteristics on the toxicities of ZnO and TiO2 nanoparticles toward human lung epithelial cells. Sci Total Environ 409:1219–1228
Tarantola M, Pietuch A, Schneider D et al (2011) Toxicity of gold-nanoparticles: Synergistic effects of shape and surface functionalization on micromotility of epithelial cells. Nanotoxicology 5:254–268
Lee M-K, Lim S-J, Kim C-K (2007) Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles. Biomaterials 28:2137–2146
Chellappa M, Anjaneyulu U, Manivasagam G, Vijayalakshmi U (2015) Preparation and evaluation of the cytotoxic nature of TiO2 nanoparticles by direct contact method. Int J Nanomedicine 10:31–41
Lippmann M (1990) Effects of fiber characteristics on lung deposition, retention, and disease. Environ Health Perspect 88:311–317
Yamamoto A, Honma R, Sumita M, Hanawa T (2004) Cytotoxicity evaluation of ceramic particles of different sizes and shapes. J Biomed Mater Res A 68:244–256
Goodman CM, McCusker CD, Yilmaz T, Rotello VM (2004) Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug Chem 15:897–900
Huang H, Lai W, Cui M et al (2016) An evaluation of blood compatibility of silver nanoparticles. Sci Rep 6:25518
King Heiden TC, Dengler E, Kao WJ et al (2007) Developmental toxicity of low generation PAMAM dendrimers in zebrafish. Toxicol Appl Pharmacol 225:70–79
Platel A, Carpentier R, Becart E et al (2016) Influence of the surface charge of PLGA nanoparticles on their in vitro genotoxicity, cytotoxicity, ROS production and endocytosis. J Appl Toxicol 36:434–444
Wang JY, Chen J, Yang J et al (2016) Effects of surface charges of gold nanoclusters on long-term in vivo biodistribution, toxicity, and cancer radiation therapy. Int J Nanomedicine 11:3475–3485
Havrdova M, Hola K, Skopalik J et al (2016) Toxicity of carbon dots-effect of surface functionalization on the cell viability, reactive oxygen species generation and cell cycle. Carbon NY 99:238–248
Kohli AK, Alpar HO (2004) Potential use of nanoparticles for transcutaneous vaccine delivery: Effect of particle size and charge. Int J Pharm 275:13–17
Bartczak D, Baradez M-O, Merson S et al (2013) Surface ligand dependent toxicity of zinc oxide nanoparticles in HepG2 cell model. J Phys Conf Ser 429:12015
Yin H, Too HP, Chow GM (2005) The effects of particle size and surface coating on the cytotoxicity of nickel ferrite. Biomaterials 26:5818–5826
Zhou Z, Son J, Harper B et al (2015) Influence of surface chemical properties on the toxicity of engineered zinc oxide nanoparticles to embryonic zebrafish. Beilstein J Nanotechnol 6:1568–1579
Bastos V, Ferreira de Oliveira JMP, Brown D et al (2016) The influence of Citrate or PEG coating on silver nanoparticle toxicity to a human keratinocyte cell line. Toxicol Lett 249:29–41
Fubini B, Hubbard A (2003) Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic Biol Med 34:1507–1516
Chen H, Wang T, Li K et al (2017) Effects of surface modification of quantum dots on viability and migration of triple-negative breast cancer cells. J Colloid Interface Sci 485:51–58
Hanot CC, Choi YS, Anani TB et al (2016) Effects of iron-oxide nanoparticle surface chemistry on uptake kinetics and cytotoxicity in CHO-K1 cells. Int J Mol Sci 17(1):54
Malvindi MA, De Matteis V, Galeone A et al (2014) Toxicity assessment of silica coated iron oxide nanoparticles and biocompatibility improvement by surface engineering. PLoS One 9:1–11
Connor EE, Mwamuka J, Gole A et al (2005) Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1:325–327
Uboldi C, Urbán P, Gilliland D et al (2016) Role of the crystalline form of titanium dioxide nanoparticles: rutile, and not anatase, induces toxic effects in Balb/3T3 mouse fibroblasts. Toxicol in Vitro 31:137–145
De Matteis V, Cascione M, Brunetti V et al (2016) Toxicity assessment of anatase and rutile titanium dioxide nanoparticles: the role of degradation in different pH conditions and light exposure. Toxicol In Vitro 37:201–210
Zhang H, Gilbert B, Huang F, Banfield JF (2003) Water driven structure transformation in nanoparticles at room temperature. Nature 424:1025–1029
Johnston CJ, Driscoll KE, Finkelstein JN et al (2000) Pulmonary chemokine and mutagenic responses in rats after subchronic inhalation of amorphous and crystalline silica. Toxicol Sci 56:405–413
Prasad RY, Wallace K, Daniel KM et al (2013) Effect of treatment media on the agglomeration of titanium dioxide nanoparticles: impact on genotoxicity, cellular interaction, and cell cycle. ACS Nano 7:1929–1942
Jiang J, Oberdörster G, Biswas P (2009) Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J Nanopart Res 11:77–89
Song Y, Li X, Du X (2009) Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma. Eur Respir J 34:559–567
Whitsett JA, Alenghat T (2015) Respiratory epithelial cells orchestrate pulmonary innate immunity. Nat Immunol 16:27–35
Yang W, Peters JI, Williams RO (2008) Inhaled nanoparticles—a current review. Int J Pharm 356:239–247
Darquenne C, Paiva M, Prisk GK (2000) Effect of gravity on aerosol dispersion and deposition in the human lung after periods of breath holding. J Appl Physiol 89:1787–1792
Tsuda A, Henry FS, Butler JP (2013) Particle transport and deposition: basic physics of particle kinetics. Compr Physiol 3:1437–1471
Geiser M, Jeannet N, Fierz M, Burtscher H (2017) Evaluating adverse effects of inhaled nanoparticles by realistic in vitro technology. Nanomaterials 7:49
Kumar A, Chen F, Mozhi A et al (2013) Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation. Nanoscale 5:8307–8325
Bergin IL, Witzmann FA (2013) Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gaps. Int J Biomed Nanosci Nanotechnol 3(1–3). doi:https://doi.org/10.1504/IJBNN.2013.054515
JAni P, Halbert GW, Langridge J, Florence AT (1990) Nanoparticle uptake by the rat gastrointestinal mucosa: quantitation and particle size dependency. J Pharm Pharmacol 42:821–826
Fröhlich EE, Fröhlich E (2016) Cytotoxicity of nanoparticles contained in food on intestinal cells and the gut microbiota. Int J Mol Sci 17(4):509
Heringa MB, Geraets L, Van Eijkeren JCH et al (2016) Risk assessment of titanium dioxide nanoparticles via oral exposure, including toxicokinetic considerations. Nanotoxicology 10:1515–1525
Randall Wickett R, Visscher MO (2006) Structure and function of the epidermal barrier. Am J Infect Control 34:s98–s110
Robertson TA, Sanchez WY, Roberts MS (2010) Are commercially available nanoparticles safe when applied to the skin? J Biomed Nanotechnol 6:452–468
Lademann J, Weigmann HJ, Rickmeyer C et al (1999) Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl Skin Physiol 12:247–256
Tan MH, Commens CA, Burnett L, Snitch PJ (1996) A pilot study on the percutaneous absorption of microfine titanium dioxide from sunscreens. Australas J Dermatol 37:185–187
Crosera M, Prodi A, Mauro M et al (2015) Titanium dioxide nanoparticle penetration into the skin and effects on HaCaT cells. Int J Environ Res Public Health 12:9282–9297
Larese F, Mauro M, Adami G, Bovenzi MCM (2015) Nanoparticles skin absorption: new aspects for a safety profile evaluation. Regul Toxicol Pharmacol 72:310–322
Tak YK, Pal S, Naoghare PK, Rangasamy S (2015) Shape-dependent skin penetration of silver nanoparticles: does it really matter? Sci Rep 5:16908
Balogh L, Nigavekar SS, Nair BM et al (2007) Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models. Nanomedicine Nanotechnol Biol Med 3:281–296
Yang Y, Qin Z, Zeng W et al (2017) Toxicity assessment of nanoparticles in various systems and organs. Nanotechnol Rev 6(3):279–289
Longmire M, Choyke PL, Kobayashi H (2008) Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond) 3(5):703–717
Blanco E, Shen H, Ferrari M (2015) Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol 33(9):941–951
Doudi M, Setorki M (2014) The acute liver injury in rat caused by gold nanoparticles. Nanomedicine J 1:248–257
Gaiser BK, Hirn S, Kermanizadeh A et al (2012) Effects of silver nanoparticles on the liver and hepatocytes in vitro. Toxicol Sci 131:537–547
Tang J, Xiong L, Zhou G et al (2010) Silver nanoparticles crossing through and distribution in the blood-brain barrier In vitro. J Nanosci Nanotechnol 10(10):6313–6317
Choi HS, Liu W, Misra P et al (2007) Renal clearance of nanoparticles. Nat Biotechnol 25:1165–1170
Lei R, Wu C, Yang B et al (2008) Integrated metabolomic analysis of the nano-sized copper particle-induced hepatotoxicity and nephrotoxicity in rats: a rapid in vivo screening method for nanotoxicity. Toxicol Appl Pharmacol 232:292–301
Weissleder R, Nahrendorf M, Pittet MJ (2014) Imaging macrophages with nanoparticles. Nat Mater 13:125–138
Wu J, Liu W, Xue C et al (2009) Toxicity and penetration of TiO2 nanoparticles in hairless mice and porcine skin after subchronic dermal exposure. Toxicol Lett 191:1–8
Zhao Y, Xing G, Chai Z (2008) Nanotoxicology: are carbon nanotubes safe? Nat Nanotechnol 3:191–192
Cooper GM (2000) The cell: molecular approach. ASM Press, Washington, DC
Kafshgari MH, Harding FJ, Voelcker NH (2015) Insights into cellular uptake of nanoparticles. Curr Drug Deliv 12(1):63–77
Zhao F, Zhao Y, Liu Y et al (2011) Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small 7:1322–1337
Shang L, Nienhaus K, Nienhaus GU (2014) Engineered nanoparticles interacting with cells: size matters. J Nanobiotechnol 12:5
Johannes L, Lamaze C (2002) Clathrin-dependent or not: is it still the question? Traffic 3(7):443–451
Aderem A, Underhill DM (1999) Mechanisms of phagocytosis in macrophages. Annu Rev Immunol 17:593–562
Conner SD, Schmid SL (2003) Regulated portals of entry into the cell. Nature 422(6927):37–44
Pelkmans L, Helenius A (2002) Endocytosis via caveolae. Traffic 3(5):311–320
Rejman J, Oberle V, Zuhorn IS et al (2004) Size-dependent internalization of particles via the pathways of clathrinand caveolae-mediated endocytosis. Biochem J 1:159–169
Saikia J, Yazdimamaghani M, Pouya S et al (2016) Differential protein adsorption and cellular uptake of silica nanoparticles based on size and porosity. ACS Appl Mater Interfaces 8(50):34820–34832
Pritz CO, Bitsche M, Salvenmoser W et al (2013) Endocytic trafficking of silica nanoparticles in a cell line derived from the organ of Corti. Nanomedicine 8:239–252
Greulicha C, Diendorfb J, Simonc T et al (2011) Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. Acta Biomater 7:347–354
Thurn KT, Arora H, Paunesku T et al (2011) Endocytosis of titanium dioxide nanoparticles in prostate cancer PC-3M cells. Nanomedicine Nanotechnol Biol Med 7:123–130
Mizuhara T, Saha K, Moyano DF et al (2015) Acylsulfonamide-Functionalized zwitterionic gold nanoparticles for enhanced cellular uptake at tumor pH. Angew Chemie-Int Ed 54:6567–6570
Wang Z, Xia T, Liu S (2015) Mechanisms of nanosilver-induced toxicological effects: more attention should be paid to its sublethal effects. R Soc Chem 7:7470–7481
Verissimo TV, Santos NT, Silva JR et al (2016) In vitro cytotoxicity and phototoxicity of surface-modified gold nanoparticles associated with neutral red as a potential drug delivery system in phototherapy. Mater Sci Eng C 65:199–204
Hashemi E, Akhavan O, Shamsara M et al (2016) Synthesis and cyto-genotoxicity evaluation of graphene on mice spermatogonial stem cells. Colloids Surf B: Biointerfaces 146:770–776
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
Olbrich C, Bakowsky U, Lehr CM et al (2001) Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA. J Control Release 77:345–355
Wong Shi Kam N, Dai H (2005) Carbon nanotubes as intracellular protein transporters: generality and biological functionality. J Am Chem Soc 127:6021–6026
Shenoy D, Fu W, Li J (2005) Surface functionalization of gold nanoparticles using hetero-bifunctional poly(ethylene glycol) spacer for intracellular tracking and delivery. Int J Nanomedicine 1(1):51–57
Wang H, Joseph JA (1999) Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reade. Free Radic Biol Med 27:612–616
Ostling JK (1984) Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. Biochem Biophys Res Commun 30:291–298
Singh NP, McCoy MT, Tice RR et al (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 175:184–191
Castiglioni S, Caspani C, Cazzaniga A et al (2014) Short- and long-term effects of silver nanoparticles on human microvascular endothelial cells. World J Biol Chem 26:457–464
Boverhof DR, Bramante CM, Butala JH et al (2015) Comparative assessment of nanomaterial definitions and safety evaluation considerations. Regul Toxicol Pharmacol 73:137–150
Musazzi UM, Marini V, Casiraghi A et al (2017) Is the European regulatory framework sufficient to assure the safety of citizens using health products containing nanomaterials? Drug Discov Today 22(6):870–882
Commission of the European Communities (2005) Communication from the Commission to the Council, the European Parliament and the Economic and Social Committee. Nanosciences and nanotechnologies: an action plan for Europe 2005–2009
European Parliament (2006) Resolution on Nanosciences and nanotechnologies: an action plan for Europe 2005–2009
Commission of the European Communities (2008) Communication from the Commission to the European Parliament, the Council and the European Economic and Social Committee. Regulatory aspects of nanomaterial
Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products. Off. J. EU L.342, 59–209. J. EU L.342, 59–209
Commission E (2011) Commission Recommendation of 18 October 2011 on the definition of nanomaterial (2011/696/EU). EU, ff. J. L. 275, 38–40.
Council of the European Union (2016 Proposal for a regulation of the European parliament and of the council on medical devices, and amending directive 2011/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009. Council of the European Union
SCENIHR (2010) Scientific basis for the definition of the term “Nanomaterial”
Lövestam G et al. (2010) JRC reference report: considerations on a definition of nanomaterial for regulatory purposes (EUR 24403 EN), European Union
Domingos RF, Baalousha MA, Ju-Nam Y et al (2009) Characterizing manufactured nanoparticles in the environment: multimethod determination of particle sizes. Environ Sci Technol 43:7277–7284
Roebben G et al. (2014) JRC science and policy report: towards a review of the EC recommendation for a definition of the term “Nanomaterial”. Part 2: assessment of collected information concerning the experience with the definition. Eur. Union
(2011) https://www.nano.gov/sites/default/files/pub_resource/nni_2011_ehs_research_strategy.pdf
Raies AB, Bajic VB (2016) In silico toxicology: computational methods for the prediction of chemical toxicity. Wiley Interdiscip Rev Comput Mol Sci 6:147–172
Ying J, Zhang T, Tang M (2015) Metal oxide nanomaterial QNAR models: available structural descriptors and understanding of toxicity mechanisms. Nanomaterials 5:1620–1637
Fourches D, Pu D, Tropsha A (2011) Exploring quantitative nanostructure—activity relationships (QNAR) modeling as a tool for predicting biological effects of manufactured nanoparticles. Comb Chem High Throughput Screen 1;14(3):217–225
Damoiseaux R, George S, Li M et al (2011) No time to lose—high throughput screening to assess nanomaterial safety. Nanoscale 3:1345–1360
Clark KA, White RH, Silbergeld EK (2011) Predictive models for nanotoxicology: current challenges and future opportunities. Regul Toxicol Pharmacol 59:361–363
Todeschini RCV (2000) Handbook of molecular descriptors. Wiley-VCH, Weinheim, pp 927–933
Mukherjee D, Royce SG, Sarkar S et al (2014) Modeling in vitro cellular responses to silver nanoparticles. J Toxicol 2014:852890. 13
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 The Author(s)
About this chapter
Cite this chapter
De Matteis, V., Rinaldi, R. (2018). Toxicity Assessment in the Nanoparticle Era. In: Saquib, Q., Faisal, M., Al-Khedhairy, A., Alatar, A. (eds) Cellular and Molecular Toxicology of Nanoparticles. Advances in Experimental Medicine and Biology, vol 1048. Springer, Cham. https://doi.org/10.1007/978-3-319-72041-8_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-72041-8_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-72040-1
Online ISBN: 978-3-319-72041-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)